Skip to main content
. Author manuscript; available in PMC: 2014 Jan 28.
Published in final edited form as: Am J Hematol. 2012 Aug 7;87(11):1017–1021. doi: 10.1002/ajh.23306

Table IC. Baseline total hemoglobin and % HbF in individual subjects. Hydroxyurea treatment status is designated in the far right column.

ID Group Hb (g/dL) HbF (%) HU
90301 Placebo 10.0 3.0 Yes
90803 Placebo 8.7 18.3 Yes
91101 Placebo 7.4 2.5
91103 Placebo 9.9 10.8 Yes

90101 10 mg/kg 9.2 7.7 Yes
90102 10 mg/kg 8.8 5.8 Yes
90103 10 mg/kg 11.9 14.7 Yes
90202 10 mg/kg 9.3 8.4
90203 10 mg/kg 8.0 2.9
91102 10 mg/kg 6.1 1.7
91104 10 mg/kg 5.9 12.2 Yes

90105 20 mg/kg 9.5 32.8 Yes
90204 20 mg/kg 8.5 8.3
90205 20 mg/kg 9.2 7.0
90801 20 mg/kg 11.8 10.2 Yes
90802 20 mg/kg 9.9 28.2 Yes
90901 20 mg/kg 11.4 12.2

90106 30 mg/kg 10.3 13.0
90206 30 mg/kg 6.3 6.4
90804 30 mg/kg 9.5 19.8 Yes
90805 30 mg/kg 8.4 2.9
90806 30 mg/kg 10.2 8.7 Yes
90902 30 mg/kg 7.5 3.7
91301 30 mg/kg 7.6 22.2